Bird Flu Creates “Opportunity” For AirShield In Immune Category, Leiner Says
This article was originally published in The Tan Sheet
The avian flu scare has created an "opportunity" for Leiner's immune system supplement AirShield, the firm said during a second-quarter 2006 earnings call
You may also be interested in...
Leiner Health Products completes its acquisition of "substantially all" assets related to Pharmaceutical Formulations' (PFI) "solid dose pharmaceutical products business" for $23 mil. in cash, Leiner announces Sept. 26. In addition to opportunities in pain management in both OTC and supplement areas, the acquisition "allows us to enhance our contract manufacturing capabilities and expands our OTC product offering and customer base," CEO Robert Kaminski says. Leiner concurrently announces that it has amended its credit agreement, which "will enhance the company's flexibility to manage the business and support the acquisition." Leiner's plans to acquire PFI's assets were made known shortly after the Edison, N.J.-based company declared bankruptcy in July (1"The Tan Sheet" July 18, 2005, p. 4)...
Increased ibuprofen opportunities from the planned acquisition of Pharmaceutical Formulations, Inc. (PFI) will help build Leiner's pain management category to $200 mil. by the end of the year, CEO Bob Kaminski claimed Aug. 10
Energizer Holdings will gain Banana Boat and Hawaiian Tropic - the No. 2- and No. 4-selling sun- care brands, respectively - through its $1.9 billion purchase of Playtex Products, the companies announce July 12